- Home
- ZVSA vs BTTR Comparison
ZVSA vs BTTR Comparison
Compare ZVSA & BTTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVSA
- BTTR
- Stock Information
- Founded
- ZVSA 2014
- BTTR 1986
- Country
- ZVSA United States
- BTTR United States
- Employees
- ZVSA N/A
- BTTR N/A
- Industry
- ZVSA Biotechnology: Pharmaceutical Preparations
- BTTR Beverages (Production/Distribution)
- Sector
- ZVSA Health Care
- BTTR Consumer Staples
- Exchange
- ZVSA Nasdaq
- BTTR Nasdaq
- Market Cap
- ZVSA 2.8M
- BTTR 4.9M
- IPO Year
- ZVSA N/A
- BTTR N/A
- Fundamental
- Price
- ZVSA $2.51
- BTTR $2.30
- Analyst Decision
- ZVSA Strong Buy
- BTTR
- Analyst Count
- ZVSA 1
- BTTR 0
- Target Price
- ZVSA $240.00
- BTTR N/A
- AVG Volume (30 Days)
- ZVSA 93.2K
- BTTR 64.4K
- Earning Date
- ZVSA 08-09-2024
- BTTR 08-13-2024
- Dividend Yield
- ZVSA N/A
- BTTR N/A
- EPS Growth
- ZVSA N/A
- BTTR N/A
- EPS
- ZVSA N/A
- BTTR N/A
- Revenue
- ZVSA N/A
- BTTR $35,264,000.00
- Revenue This Year
- ZVSA N/A
- BTTR $92.41
- Revenue Next Year
- ZVSA N/A
- BTTR $13.46
- P/E Ratio
- ZVSA N/A
- BTTR N/A
- Revenue Growth
- ZVSA N/A
- BTTR N/A
- 52 Week Low
- ZVSA $2.50
- BTTR $1.92
- 52 Week High
- ZVSA $79.80
- BTTR $23.20
- Technical
- Relative Strength Index (RSI)
- ZVSA 38.18
- BTTR 37.27
- Support Level
- ZVSA $2.71
- BTTR $1.92
- Resistance Level
- ZVSA $2.89
- BTTR $2.66
- Average True Range (ATR)
- ZVSA 0.37
- BTTR 0.34
- MACD
- ZVSA 0.00
- BTTR -0.06
- Stochastic Oscillator
- ZVSA 0.00
- BTTR 27.54
About ZVSA ZyVersa Therapeutics Inc.
ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary globally licensed drug development platforms which are Cholesterol Efflux MediatorTM, VAR 200 (2-hydroxypropyl-beta-cyclodextrin) is an injectable drug in clinical development for the treatment of renal diseases. and IC 100 is a monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of inflammatory conditions.
About BTTR Better Choice Company Inc.
Better Choice Co Inc is a pet health and wellness portfolio company, offering consumers a wide variety of recognized premium pet products and hemp-derived CBD supplements. Its portfolio includes kibble and canned dog and cat food, freeze-dried raw dog food and treats, vegan dog food and treats, oral care products, supplements and grooming aids. Its core products sold under the Halo brand are sustainably sourced, derived from real whole meat and no rendered meat meal and include non-GMO fruits and vegetables. Its core products sold under the TruDog brand are made according to nutritional philosophy of fresh, meat-based nutrition and minimal processing.